Clinical Trial Update: A Trial Evaluating Omission of Radiotherapy to Regional Lymphatic's [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial is evaluating the omission of radiotherapy to regional lymphatics in head and neck cancer; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Snippet

Sponsor: All India Institute of Medical Sciences | Conditions: Head and Neck Cancer | Phase 2, Phase 3 | Status: RECRUITING